风险因素和原因 romosozumab 在一个病例控制研究中的不遵守
Ting-Chien Tsai1, Yun-Shan Yen2, Chang-Hao Lin1
1Department of Orthopaedics, Ditmanson Medical Foundation Chia-Yi Christian Hospital, Chia-Yi, Taiwan.
Scientific reports
|July 2, 2025
概括
男性患者和那些为药物自费的人面临着更高的罗莫苏祖马布不服药的风险. 与患者相关的因素是遗漏骨质疏松症治疗注射的主要原因.
科学领域:
- 骨质疏松症管理管理
- 药物治疗 坚持药物治疗
- 患者的治疗结果.
背景情况:
- 罗莫苏祖马布是骨质疏松症的关键治疗方法.
- 了解不坚持罗莫苏祖马布治疗对于改善患者的治疗结果至关重要.
- 风险因素和罗莫苏祖马布不服药的原因尚未明确.
研究的目的:
- 为了比较坚持罗莫苏祖马布治疗的患者与不坚持治疗的患者.
- 为了确定与罗莫苏祖马布不依附相关的潜在风险因素.
- 探索骨质疏松症患者治疗不坚持的主要原因.
主要方法:
- 采用了一种病例控制研究设计.
- 分析了在2022年2月至2024年3月期间接受罗莫祖马布的患者.
- 单变量和逻辑回归分析确定了患者特征与不坚持之间的关联.
主要成果:
- 男性患者表现出明显更高的不坚持的风险 (9.03倍).
- 罗莫苏祖马布的自我支付与增加的不服药风险 (2.756倍) 有关.
- 与患者相关的因素 (87.0%) 是不遵守的主要原因,其次是与药物相关的 (8.7%) 和与卫生系统相关的因素 (4.3%).
结论:
- 男性的性别和自我支付被确定为罗莫苏祖马布不服药的风险因素.
- 与患者相关的因素是导致骨质疏松症治疗不坚持的主要原因.
- 结果可以为医疗保健提供者提供信息,帮助他们制定有针对性的干预措施,以改善遵守.
相关概念视频
Types of Biopharmaceutical Studies: Controlled and Non-Controlled Approaches
182
Biopharmaceutical studies constitute a vital field aiming to enhance drug delivery methods and refine therapeutic approaches, drawing upon diverse interdisciplinary knowledge. In research methodologies, the choice between controlled and non-controlled studies significantly influences the study's reliability and accuracy.
Non-controlled studies, commonly employed for initial exploration, lack a control group, rendering them susceptible to biases and external influences. In contrast,...
Non-controlled studies, commonly employed for initial exploration, lack a control group, rendering them susceptible to biases and external influences. In contrast,...
182
Factors Affecting the Risk of Infection
12.3K
The hosts' susceptibility to infection depends on several factors. The integrity of the skin and mucous membranes helps protect the body against microbial attacks. When the skin is altered, the chance of infection, limb loss, and even death increases.
The integrity and count of the white blood cells help the body resist pathogens and fight infection. When impaired, it reduces the body's resistance to pathogens. The acidic pH levels of the gastrointestinal, genitourinary tracts, and skin...
The integrity and count of the white blood cells help the body resist pathogens and fight infection. When impaired, it reduces the body's resistance to pathogens. The acidic pH levels of the gastrointestinal, genitourinary tracts, and skin...
12.3K
Factors Affecting Protein-Drug Binding: Patient-Related Factors
119
Protein-drug binding, a pivotal aspect of pharmacokinetics, is subject to considerable variability influenced by an array of patient-related factors. The intricate interplay of age, individual differences, and pathological conditions significantly impact the binding dynamics and subsequent pharmacological effects.
Age stands as a key determinant in protein-drug binding. Neonates, characterized by low albumin content, experience heightened concentrations of unbound drugs such as phenytoin and...
Age stands as a key determinant in protein-drug binding. Neonates, characterized by low albumin content, experience heightened concentrations of unbound drugs such as phenytoin and...
119
Relative Risk
361
Relative risk (RR) is a statistical measure commonly used in epidemiology to compare the likelihood of a particular event occurring between two groups. This metric is important for evaluating the relationship between exposure to a specific risk factor and the probability of a particular outcome. It plays a crucial role in medical research, public health studies, and risk assessment. Relative risk quantifies how much more (or less) likely an event is to occur in an exposed group compared to an...
361
Bias in Epidemiological Studies
700
Biases can arise at various stages of research, from study design and data collection to analysis and interpretation. Recognizing and addressing these biases is essential to ensure the validity and reliability of epidemiological findings.Broadly speaking, biases in epidemiology fall into three main categories: selection bias, information bias, and confounding. A more detailed description of possible biases is:
700
Confounding in Epidemiological Studies
272
Confounding in statistical epidemiology represents a pivotal challenge, referring to the distortion in the perceived relationship between an exposure and an outcome due to the presence of a third variable, known as a confounder. This variable is associated with both the exposure and the outcome but is not a direct link in their causal chain. Its presence can lead to erroneous interpretations of the exposure's effect, either exaggerating or underestimating the true association. This...
272


